Publication | Closed Access
Serum level of CCL2 predicts outcome of patients with pancreatic cancer.
16
Citations
19
References
2020
Year
Our results suggest that serum level of CCL2 may serve as a potential marker for predicting the outcome of patients with pancreatic cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1